Derek Archila
Stock Analyst at Wells Fargo
(4.83)
# 423
Out of 4,382 analysts
908
Total ratings
52.9%
Success rate
17.3%
Average return
Main Sectors:
Stocks Rated by Derek Archila
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Reiterated: Buy | $1,260 → $1,291 | $891.32 | +44.84% | 74 | Jun 2, 2026 | |
| ARVN Arvinas | Maintained: Buy | $15 | $7.42 | +102.16% | 25 | May 22, 2026 | |
| IMVT Immunovant | Reiterated: Buy | $45 | $31.11 | +44.65% | 29 | May 21, 2026 | |
| ATYR aTyr Pharma | Rated: Hold | $1 | $0.47 | +112.77% | 12 | May 18, 2026 | |
| SEPN Septerna | Rated: Buy | $48 | $31.15 | +54.09% | 10 | May 18, 2026 | |
| ALMS Alumis | Reiterated: Buy | $49 → $51 | $19.06 | +167.58% | 8 | May 15, 2026 | |
| CLDX Celldex Therapeutics | Rated: Buy | $38 → $54 | $28.62 | +88.68% | 19 | May 13, 2026 | |
| CCCC C4 Therapeutics | Rated: Buy | $10 | $3.85 | +159.74% | 13 | May 13, 2026 | |
| INCY Incyte | Maintained: Hold | $101 | $102.38 | -1.35% | 36 | May 12, 2026 | |
| KYTX Kyverna Therapeutics | Rated: Buy | $33 | $7.47 | +341.77% | 13 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 | $67.61 | +44.95% | 6 | May 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $330 → $326 | $210.45 | +54.91% | 43 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $143 → $144 | $86.40 | +66.67% | 59 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $7.50 | +233.33% | 11 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 | $52.70 | -33.59% | 28 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 → $28 | $14.64 | +91.26% | 22 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $5.29 | +410.40% | 19 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $29 → $20 | $15.78 | +26.74% | 16 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.54 | +224.68% | 1 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 → $29 | $16.37 | +77.15% | 16 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 | $13.11 | -23.72% | 7 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $78 → $79 | $67.00 | +17.91% | 4 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $116 | $74.13 | +56.48% | 22 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $479 → $376 | $303.05 | +24.07% | 4 | Jan 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $56 | $64.47 | -13.14% | 4 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $81 | $50.37 | +60.81% | 27 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $73 | $70.97 | +2.86% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $29.00 | +248.28% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $61.85 | -49.88% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $40 → $30 | $26.09 | +14.99% | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $2 | $3.25 | -38.46% | 16 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 | $24.04 | -41.76% | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $3.66 | +36.61% | 17 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $180 | $57.67 | n/a | 1 | Dec 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $11.16 | $1.44 | n/a | 1 | Dec 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $2.94 | n/a | 11 | Jun 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $0.4274 | n/a | 34 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $5.84 | n/a | 20 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $26.85 | n/a | 27 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $96 → $97 | $28.02 | n/a | 15 | May 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $126 → $130 | $486.98 | n/a | 10 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $37 → $20 | $3.13 | n/a | 24 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $6 | $16.59 | n/a | 20 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $13.93 | n/a | 28 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $28.45 | n/a | 11 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €15.62 → €16.48 | $3.50 | n/a | 2 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $19 | $4.03 | n/a | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €287.17 → €288.90 | $729.53 | n/a | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €91.09 → €96.00 | $24.40 | n/a | 2 | Feb 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €11.00 | $8.77 | n/a | 7 | Sep 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $22.75 | n/a | 14 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.03 | n/a | 31 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $10.61 | n/a | 12 | Apr 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.0111 | n/a | 11 | Mar 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 | $10.83 | n/a | 6 | Mar 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $34.19 | n/a | 18 | Feb 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.27 | n/a | 8 | Nov 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $15.88 | n/a | 1 | Oct 3, 2017 |
argenx SE
Jun 2, 2026
Reiterated: Buy
Price Target: $1,260 → $1,291
Current: $891.32
Upside: +44.84%
Arvinas
May 22, 2026
Maintained: Buy
Price Target: $15
Current: $7.42
Upside: +102.16%
Immunovant
May 21, 2026
Reiterated: Buy
Price Target: $45
Current: $31.11
Upside: +44.65%
aTyr Pharma
May 18, 2026
Rated: Hold
Price Target: $1
Current: $0.47
Upside: +112.77%
Septerna
May 18, 2026
Rated: Buy
Price Target: $48
Current: $31.15
Upside: +54.09%
Alumis
May 15, 2026
Reiterated: Buy
Price Target: $49 → $51
Current: $19.06
Upside: +167.58%
Celldex Therapeutics
May 13, 2026
Rated: Buy
Price Target: $38 → $54
Current: $28.62
Upside: +88.68%
C4 Therapeutics
May 13, 2026
Rated: Buy
Price Target: $10
Current: $3.85
Upside: +159.74%
Incyte
May 12, 2026
Maintained: Hold
Price Target: $101
Current: $102.38
Upside: -1.35%
Kyverna Therapeutics
May 12, 2026
Rated: Buy
Price Target: $33
Current: $7.47
Upside: +341.77%
May 9, 2026
Reiterated: Buy
Price Target: $98
Current: $67.61
Upside: +44.95%
May 8, 2026
Maintained: Buy
Price Target: $330 → $326
Current: $210.45
Upside: +54.91%
May 6, 2026
Reiterated: Buy
Price Target: $143 → $144
Current: $86.40
Upside: +66.67%
May 5, 2026
Reiterated: Buy
Price Target: $25
Current: $7.50
Upside: +233.33%
Apr 14, 2026
Maintained: Hold
Price Target: $35
Current: $52.70
Upside: -33.59%
Apr 9, 2026
Rated: Buy
Price Target: $29 → $28
Current: $14.64
Upside: +91.26%
Apr 1, 2026
Reiterated: Buy
Price Target: $27
Current: $5.29
Upside: +410.40%
Mar 31, 2026
Reiterated: Hold
Price Target: $29 → $20
Current: $15.78
Upside: +26.74%
Mar 19, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $1.54
Upside: +224.68%
Mar 18, 2026
Rated: Buy
Price Target: $30 → $29
Current: $16.37
Upside: +77.15%
Mar 11, 2026
Maintained: Hold
Price Target: $10
Current: $13.11
Upside: -23.72%
Mar 2, 2026
Maintained: Buy
Price Target: $78 → $79
Current: $67.00
Upside: +17.91%
Mar 2, 2026
Maintained: Buy
Price Target: $116
Current: $74.13
Upside: +56.48%
Jan 20, 2026
Maintained: Hold
Price Target: $479 → $376
Current: $303.05
Upside: +24.07%
Dec 16, 2025
Maintained: Sell
Price Target: $56
Current: $64.47
Upside: -13.14%
Dec 16, 2025
Maintained: Buy
Price Target: $51 → $81
Current: $50.37
Upside: +60.81%
Oct 17, 2025
Maintained: Buy
Price Target: $73
Current: $70.97
Upside: +2.86%
Oct 17, 2025
Maintained: Buy
Price Target: $101
Current: $29.00
Upside: +248.28%
Oct 17, 2025
Maintained: Buy
Price Target: $31
Current: $61.85
Upside: -49.88%
Aug 12, 2025
Maintained: Hold
Price Target: $40 → $30
Current: $26.09
Upside: +14.99%
Aug 8, 2025
Maintained: Hold
Price Target: $3 → $2
Current: $3.25
Upside: -38.46%
Aug 7, 2025
Maintained: Hold
Price Target: $14
Current: $24.04
Upside: -41.76%
Aug 6, 2025
Maintained: Hold
Price Target: $6 → $5
Current: $3.66
Upside: +36.61%
Dec 6, 2021
Initiated Coverage: Buy
Price Target: $180
Current: $57.67
Upside: n/a
Dec 6, 2021
Initiated Coverage: Sell
Price Target: $11.16
Current: $1.44
Upside: n/a
Jun 13, 2021
Rated: Buy
Price Target: $12
Current: $2.94
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: $27
Current: $0.4274
Upside: n/a
May 13, 2021
Reiterated: Hold
Price Target: $3
Current: $5.84
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: $30
Current: $26.85
Upside: n/a
May 9, 2021
Reiterated: Hold
Price Target: $96 → $97
Current: $28.02
Upside: n/a
May 6, 2021
Reiterated: Hold
Price Target: $126 → $130
Current: $486.98
Upside: n/a
May 4, 2021
Downgraded: Hold
Price Target: $37 → $20
Current: $3.13
Upside: n/a
May 3, 2021
Reiterated: Hold
Price Target: $7 → $6
Current: $16.59
Upside: n/a
Apr 29, 2021
Reiterated: Hold
Price Target: $6
Current: $13.93
Upside: n/a
Apr 28, 2021
Reiterated: Buy
Price Target: $13
Current: $28.45
Upside: n/a
Mar 5, 2021
Maintained: Buy
Price Target: €15.62 → €16.48
Current: $3.50
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: $18 → $19
Current: $4.03
Upside: n/a
Mar 4, 2021
Maintained: Hold
Price Target: €287.17 → €288.90
Current: $729.53
Upside: n/a
Feb 19, 2021
Maintained: Hold
Price Target: €91.09 → €96.00
Current: $24.40
Upside: n/a
Sep 30, 2020
Reiterated: Buy
Price Target: €11.00
Current: $8.77
Upside: n/a
Jul 10, 2020
Rated: Hold
Price Target: n/a
Current: $22.75
Upside: n/a
Jul 10, 2020
Rated: Hold
Price Target: n/a
Current: $6.03
Upside: n/a
Apr 2, 2018
Reiterated: Buy
Price Target: $13
Current: $10.61
Upside: n/a
Mar 22, 2018
Maintained: Buy
Price Target: n/a
Current: $0.0111
Upside: n/a
Mar 5, 2018
Reiterated: Buy
Price Target: $98
Current: $10.83
Upside: n/a
Feb 8, 2018
Rated: Hold
Price Target: n/a
Current: $34.19
Upside: n/a
Nov 9, 2017
Maintained: Hold
Price Target: n/a
Current: $1.27
Upside: n/a
Oct 3, 2017
Maintained: Hold
Price Target: n/a
Current: $15.88
Upside: n/a